US President Joe Biden is set to announce a new set of guidelines this week that aim to protect the reproductive rights of women in the country. The announcement follows the overturning of the landmark Roe v. Wade ruling by the Supreme Court early this year.
Biden will announce the new guidelines and grants Tuesday that aim to protect reproductive rights during a meeting of the reproductive rights task force that will also be attended by Vice President Kamala Harris.
The US leader is also set to describe how abortion rights have been curtailed since the Conservative-majority Supreme Court overturned the 1973 ruling guaranteeing a woman’s right to have an abortion.
The meeting would mark 100 days since the high court overturned the ruling and will focus on how millions of women in the country are no longer allowed to access abortion services and how doctors and nurses are facing criminal penalties for providing such services, according to a White House official and a letter to Biden from Jen Klein, the head of the inter-agency task force on abortion access.
During the meeting, Biden is also set to talk about new guidelines for universities from the Education Department to protect students from discrimination on the basis of pregnancy and $6 million in new grants to protect access to reproductive healthcare from the Health and Human Services Department.
According to Klein’s letter, abortion bans have come into effect in over a dozen states since the Supreme Court overturned Roe v. Wade. Almost 30 million women of reproductive age are living in the state with an abortion ban in place, including 22 million women who cannot access abortion services after six weeks.
The letter by Klein also cited GOP Senator Lindsey Graham’s plan to introduce a national abortion ban.
Physicians and abortion rights advocates have now urged the Food and Drug Administration to get Danco Laboratories to seek the approval of mifepristone, a pill that is used in terminating early pregnancies at home for miscarriage management.
Danco, which is one of the two companies that make the pill, said it has no current plans to do so but will consider it in the future.


Iran Says It Closes Strait of Hormuz After Warning Shot at Vessel
Trump Administration Hands Over Key Evidence in Minnesota Immigration Shooting Investigations
US-Iran Strikes Escalate as Strait of Hormuz Crisis Pushes Oil Prices Higher
Ann Widdecombe Murder: Police Arrest Second Suspect, Rule Out Terrorism Motive
Iran's Supreme Leader Vows Revenge as Trump Threatens Massive U.S. Military Response
EU Weighs New Trade Restrictions on Israeli West Bank Settlements
Ukraine, Europe Launch Freyja Missile Shield to Strengthen Air Defense Against Russia
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Venezuela Appoints Felix Plasencia to Lead Foreign Relations and Trade
Western Allies Push for More Air Defenses for Ukraine at Paris Summit
Reuters/Ipsos Poll: Most Americans Expect U.S.-Iran War to Be Prolonged
Brazil Court Bars Flavio Bolsonaro From Visiting Jair Bolsonaro Ahead of Election
UK Sanctions 24 Russian-Linked Targets Over Cyberattacks and Election Interference
Israel Sets October 27 Election as Netanyahu Faces Tough Political Test
Trump Tells Congress Iran Hostilities Restarted, Citing New 60-Day War Powers Window
UN Says Hamas Disrupted Gaza Aid Distribution, Group Denies Allegations
Zelenskiy Plans Ukraine Government Shake-Up as Prime Minister Svyrydenko Set to Step Down 



